loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Technical details about Pelcitoclax, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Pelcitoclax [inn], 317ubd60ml, 1619923-36-2, Unii-317ubd60ml, Pelcitoclax [who-dd], Chembl4802151
Molecular Formula
C57H66ClF4N6O11PS4
Molecular Weight
1281.9  g/mol
InChI Key
QIOCQCYXBYUYLH-YACUFSJGSA-N
FDA UNII
317UBD60ML

Pelcitoclax is a Bcl-2 homology (BH)-3 mimetic and selective inhibitor of the anti-apoptotic proteins B-cell lymphoma 2 (Bcl-2) and Bcl-XL, with potential pro-apoptotic and antineoplastic activities. Upon administration, pelcitoclax specifically binds to and inhibits the activity of the pro-survival proteins Bcl-2 and Bcl-XL. This restores apoptotic processes and inhibits cell proliferation in Bcl-2/Bcl-XL-dependent tumor cells. Bcl-2 and Bcl-XL, proteins belonging to the Bcl-2 family that are overexpressed in many cancers, play an important role in the negative regulation of apoptosis; tumor expression is associated with increased drug resistance and cancer cell survival.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[1-[(3R)-3-[4-[[4-[4-[3-[2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl]-5-fluorophenyl]piperazin-1-yl]phenyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperidine-4-carbonyl]oxypropylphosphonic acid
2.1.2 InChI
InChI=1S/C57H66ClF4N6O11PS4/c1-38(2)68-39(3)55(82(4,73)74)53(54(68)40-11-13-43(58)14-12-40)42-33-44(59)35-48(34-42)67-29-27-66(28-30-67)47-17-15-45(16-18-47)64-84(77,78)50-19-20-51(52(36-50)83(75,76)57(60,61)62)63-46(37-81-49-9-6-5-7-10-49)23-26-65-24-21-41(22-25-65)56(69)79-31-8-32-80(70,71)72/h5-7,9-20,33-36,38,41,46,63-64H,8,21-32,37H2,1-4H3,(H2,70,71,72)/t46-/m1/s1
2.1.3 InChI Key
QIOCQCYXBYUYLH-YACUFSJGSA-N
2.1.4 Canonical SMILES
CC1=C(C(=C(N1C(C)C)C2=CC=C(C=C2)Cl)C3=CC(=CC(=C3)F)N4CCN(CC4)C5=CC=C(C=C5)NS(=O)(=O)C6=CC(=C(C=C6)NC(CCN7CCC(CC7)C(=O)OCCCP(=O)(O)O)CSC8=CC=CC=C8)S(=O)(=O)C(F)(F)F)S(=O)(=O)C
2.1.5 Isomeric SMILES
CC1=C(C(=C(N1C(C)C)C2=CC=C(C=C2)Cl)C3=CC(=CC(=C3)F)N4CCN(CC4)C5=CC=C(C=C5)NS(=O)(=O)C6=CC(=C(C=C6)N[C@H](CCN7CCC(CC7)C(=O)OCCCP(=O)(O)O)CSC8=CC=CC=C8)S(=O)(=O)C(F)(F)F)S(=O)(=O)C
2.2 Other Identifiers
2.2.1 UNII
317UBD60ML
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(1-((3r)-3-(4-((4-(4-(3-(2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl)-5-fluorophenyl)piperazin-1-yl)phenyl)sulfamoyl)-2-(trifluoromethylsulfonyl)anilino)-4-phenylsulfanylbutyl)piperidine-4-carbonyl)oxypropylphosphonic Acid

2. Apg 1252

3. Apg-1252

4. Apg1252

2.3.2 Depositor-Supplied Synonyms

1. Pelcitoclax [inn]

2. 317ubd60ml

3. 1619923-36-2

4. Unii-317ubd60ml

5. Pelcitoclax [who-dd]

6. Chembl4802151

7. Schembl15872908

8. Apg1252

9. Apg 1252 [who-dd]

10. Apg-1252

11. Nsc835773

12. Nsc-835773

13. Hy-109185

14. Cs-0116458

15. (r)-3-(1-(3-(4-(n-(4-(4-(3-(2-(4-chlorophenyl)-1-isopropyl-5-methyl-4-(methylsulfonyl)-1h-pyrrol-3-yl)-5-fluorophenyl)piperazin-1-yl)phenyl)sulfamoyl)-2-(trifluoromethylsulfonyl)phenylamino)-4-(phenylthio)butyl)piperidine-4-carbonyloxy)propylphosphonic Acid

16. 4-piperidinecarboxylic Acid, 1-((3r)-3-((4-(((4-(4-(3-(2-(4-chlorophenyl)-5-methyl-1-(1-methylethyl)-4-(methylsulfonyl)-1h-pyrrol-3-yl)-5-fluorophenyl)-1-piperazinyl)phenyl)amino)sulfonyl)-2-((trifluoromethyl)sulfonyl)phenyl)amino)-4-(phenylthio)butyl)-, 3-phosphonopropyl Ester

2.4 Create Date
2014-08-18
3 Chemical and Physical Properties
Molecular Weight 1281.9 g/mol
Molecular Formula C57H66ClF4N6O11PS4
XLogP37.5
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count21
Rotatable Bond Count24
Exact Mass1280.3034690 g/mol
Monoisotopic Mass1280.3034690 g/mol
Topological Polar Surface Area275 Ų
Heavy Atom Count84
Formal Charge0
Complexity2490
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY